Back to main

Weekly CEO Sells Highlight: Cardinal Health, Envision Healthcare Holdings, Tableau Software and ...

Posted
2/16/2014 7:32:00 PM
By: GuruFocus
Referenced Stocks:EVHC;DATA;AGN;CAH

According to GuruFocus Insider Data , these are the largest CEO sales during the past week: Cardinal Health Inc, Envision Healthcare Holdings Inc, Tableau Software Inc, and Allergan Inc.

Cardinal Health Inc ( CAH ): CEO, Pharmaceutical Segment Michael C Kaufmann sold 388,995 Shares

CEO, Pharmaceutical Segment of Cardinal Health Inc ( CAH ) Michael C Kaufmann sold 388,995 shares on 02/11/2014 at an average price of $67.46. Cardinal Health, Inc is an Ohio corporation formed in 1979. Cardinal Health Inc has a market cap of $24.09 billion; its shares were traded at around $70.27 with a P/E ratio of 65.60 and P/S ratio of 0.25. The dividend yield of Cardinal Health Inc stocks is 1.68%. Cardinal Health Inc had an annual average earnings growth of 2.80% over the past 5 years.


Cardinal Health Inc announced their 2014 second fiscal quarter results. The Company announced revenues of $22.2 billion and earnings from continuing operations of $225 million.

CEO, Pharmaceutical Segment Michael C Kaufmann sold 388,995 shares of CAH stock on 02/11/2014 at the average price of 67.46. CFO Jeffrey William Henderson sold 253,190 shares of CAH stock on 02/03/2014 at the average price of 67.19. EVP - Strategy & Corp. Dev. Mark R Blake, Chief HR Officer Carole S Watkins, Director Calvin Darden, and Director Gregory B Kenny sold 100,713 shares of CAH stock in February.

Envision Healthcare Holdings Inc ( EVHC ): President and CEO William A Sanger sold 339,348 Shares

President and CEO of Envision Healthcare Holdings Inc ( EVHC ) William A Sanger sold 339,348 shares on 02/11/2014 at an average price of $29.51. Envision Healthcare Holdings Inc offers an array of healthcare-related services to consumers, hospitals, healthcare systems, health plans and local, state and national government entities. Envision Healthcare Holdings Inc has a market cap of $6.13 billion; its shares were traded at around $33.94 with a P/E ratio of 303.00 and P/S ratio of 1.32.

Envision Healthcare Holdings Inc announced their 2013 third quarter results with revenues of $955.9 million and net loss of $7.7 million.

President and CEO William A Sanger sold 339,348 shares of EVHC stock on 02/11/2014 at the average price of 29.51. EVP, COO and CFO Randel G Owen sold 163,596 shares of EVHC stock on 02/11/2014 at the average price of 29.51. EVP, CSO & Treasurer Steve W Jr Ratton, President of AMR Horne Edward Van, SVP of Gov. & Nat. Services Steven G Murphy, SVP of Human Resources Kim Norman, and SVP, Gen. Counsel & Secretary Craig A. Wilson sold 69,068 shares of EVHC stock in February.

Tableau Software Inc ( DATA ): CEO, Co-Founder and Chairman Christian Chabot sold 300,000 Shares

CEO, Co-Founder and Chairman of Tableau Software Inc ( DATA ) Christian Chabot sold 300,000 shares on 02/11/2014 at an average price of $89.21. Tableau Software Inc was formed as Tableau Software LLC, a Delaware limited liability company, in 2003 and incorporated as Tableau Software, Inc. Tableau Software Inc has a market cap of $5.79 billion; its shares were traded at around $98.08 with and P/S ratio of 31.95.

Tableau Software Inc reported their 2013 annual results. The Company announced revenues of $232.4 million and net income of $7.1 million.

CEO, Co-Founder and Chairman Christian Chabot sold 500,000 shares of DATA stock in November and February. CFO Thomas E Walker Jr sold 246,100 shares of DATA stock in October, November, and February. Executive VP, Sales Kelly Wright, CDO and Co-Founder Chris Stolte, VP, GC & Secretary Keenan Michael Conder, and Director A Brooke Seawell sold 458,788 shares of DATA stock in December and February.

Allergan, Inc. ( AGN ): Chairman of the Board and CEO David E I Pyott sold 252,000 Shares

Chairman of the Board and CEO of Allergan, Inc. ( AGN ) David E I Pyott sold 252,000 shares on 02/12/2014 at an average price of $123.12. Allergan, Inc., was founded in 1950 and incorporated in Delaware in 1977. Allergan, Inc. has a market cap of $37.02 billion; its shares were traded at around $124.57 with a P/E ratio of 37.80 and P/S ratio of 6.04. The dividend yield of Allergan, Inc. stocks is 0.16%. Allergan, Inc. had an annual average earnings growth of 29.40% over the past 10 years. GuruFocus rated Allergan, Inc. the business predictability rank of 2.5-star.

Allergan Inc announced revenues of $1.7 billion and net income of $312.3 million for their 2013 fourth quarter results.

Chairman of the Board and CEO David E I Pyott sold 252,000 shares of AGN stock on 02/12/2014 at the average price of 123.12. EVP, Fin & Bus. Dev., CFO Jeffrey L Edwards sold 105,500 shares of AGN stock on 02/07/2014 at the average price of 117.74. 10% Security Holder David Brian Elliott and Director Eric Roth bought 48,500 shares of AGN stock in October and November.

For the complete list of stocks that bought by their CEOs, go to: Insider Buys.

About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .

This article first appeared on GuruFocus .